Japanese API Manufacturer to Remain on Import Alert for CGMP Violations
The Food and Drug Administration will continue to refuse imports of active pharmaceutical ingredients (API) manufactured by Japanese company Asada Milling Co., Ltd.’s facility in Kanra, Japan, it said in a warning letter. The products at the facility were already…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
subject to import alert for current good manufacturing practice violations. The company failed to correct the problems, FDA said.